Interestingly, results indicate that SAS treatment increased transferrin and STEAP-3 expression, while decreased ferritin, SLC7A11, and GPx-4 expression, which are the major drivers that protect the tumor cells from ferroptosis. The gene discussed is STEAP3; the disease is neoplasm.